ICU – seastar medical holding corporation (US:NASDAQ)

News

SeaStar Medical (ICU) had its "sell (e+)" rating reaffirmed by Weiss Ratings.
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com